AcuNav biosense webster

Register to receive a free U.S. Market for Electrophysiology and Cardiac Ablation Devices report synopsis and brochure

Diagnostic electrophysiology (EP) devices are used for monitoring electrical signals in the heart. EP studies are used either to diagnose arrhythmias or to assist in cardiac ablation procedures. According to a recent report by iData Research, the total market for diagnostic electrophysiology (EP) devices was valued at nearly a billion dollars. In 2015, conventional diagnostic EP catheters represented the largest portion of the market. The market for conventional EP catheters is expected to grow the fastest due to the increased establishment of EP labs every year in the United States.

Diagnostic EP catheters are used for temporary intracardiac sensing, recording, stimulation and mapping. These catheters are almost always used in conjunction with cardiac ablation procedures, although they can also be used during procedures not involving ablation, such as pacemaker, implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device implantation.

The overall average selling price (ASP) of diagnostic EP catheters will decrease at a relatively low rate due to the introduction of more advanced steerable and mapping catheters. Unit growth has accelerated, coinciding with the FDA approval of Biosense Webster’s radiofrequency (RF) catheters for the treatment of atrial fibrillation. Other cardiac ablation catheters are expected to be approved by the FDA. In addition, the number of cardiac ablation procedures to treat ventricular tachycardia (VT) is expected to increase by 2022. An increased number of catheter-based cardiac ablation procedures leads to a greater demand for diagnostic EP catheters.

This year, Biosense Webster, a subsidiary of Johnson & Johnson, was the leading competitor in the diagnostic electrophysiology device market. The company was also the market leader in the intracardiac echocardiography (ICE) catheter market through sales of the AcuNav™ ultrasound catheter. Other competitors include St. Jude Medical, Boston Scientific, Biotronik, MicroPort and SterilMed among others.

For Further Information
More on the markets for electrophysiology and cardiac ablation devices can be found in our report published by iData entitled U.S. Market for Electrophysiology and Cardiac Ablation Devices, which covers the U.S. as a whole, as well as market segments for electrophysiology and cardiac ablation, electrophysiology lab devices, diagnostic EP catheters, and cardiac ablation catheters.

The iData series on the market for electrophysiology and cardiac ablation devices also covers 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at [email protected] for an U.S. Market for Electrophysiology and Cardiac Ablation Devices report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: